Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/II Study to Evaluate the Efficacy and Tolerability of PM01183 in Combination With Olaparib in Patients With Advanced Solid Tumors

NCT02684318 is registered in ClinicalTrials.gov with Poveda, Andrés, M.D. as lead sponsor.

NCT NCT02684318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02684318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/II Study to Evaluate the Efficacy and Tolerability of PM01183 in Combination With Olaparib in Patients With Advanced Solid Tumors
Lead sponsor
Poveda, Andrés, M.D.
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 31, 2015
Completion date
October 31, 2019
Enrollment
100 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, breast cancer, endometrial cancer, ovarian cancer